A review on how the latest computational methods that utilize facial, acoustic, and semantic features are being deployed to predict major depressive disorders.
Specialised Therapeutics partners Treeway to license ALS drug
TW001 is intended for the treatment of amyotrophic lateral sclerosis. Credit: Green Apple/Shutterstock.com. Specialised Therapeutics (ST) has entered into a licensing agreement with Dutch biotech